Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


16.10.2017

3 Ann Neurol
1 Diabetes Res Clin Pract
2 Intern Med
1 J Autoimmun
1 J Clin Endocrinol Metab
3 J Immunol
5 J Neuroimmunol
1 Mult Scler
5 N Engl J Med
2 Neurology
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. AZODI S, Nair G, Enose-Akahata Y, Charlip E, et al
    Imaging Spinal Cord Atrophy in Progressive Myelopathies: HTLV-I Associated Neurologic Disease (HAM/TSP) and Multiple Sclerosis (MS).
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25072.
    PubMed     Text format     Abstract available

  2. JENDE JME, Hauck GH, Diem R, Weiler M, et al
    Peripheral nerve involvement in multiple sclerosis Demonstration by magnetic resonance neurography.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25068.
    PubMed     Text format     Abstract available

  3. FITZGERALD KC, Munger KL, Ascherio A
    Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".
    Ann Neurol. 2017 Sep 29. doi: 10.1002/ana.25055.
    PubMed     Text format    


    Diabetes Res Clin Pract

  4. WOD M, Yderstraede KB, Halekoh U, Beck-Nielsen H, et al
    Metabolic risk profiles in diabetes stratified according to age at onset, islet autoimmunity and fasting C-peptide.
    Diabetes Res Clin Pract. 2017 Oct 5. pii: S0168-8227(17)31091.
    PubMed     Text format     Abstract available


    Intern Med

  5. KURUSHIMA S, Horai Y, Takatani A, Nishino A, et al
    Phalangeal Microgeodic Syndrome in a Patient with Systemic Lupus Erythematosus.
    Intern Med. 2017 Oct 11. doi: 10.2169/internalmedicine.9195.
    PubMed     Text format     Abstract available

  6. NAKAE Y, Hyuga M, Kishimoto W, Fukunaga A, et al
    Multiple Myeloma Presenting with Autoimmune Autonomic Ganglionopathy.
    Intern Med. 2017 Oct 11. doi: 10.2169/internalmedicine.9096.
    PubMed     Text format     Abstract available


    J Autoimmun

  7. LING Q, Lu J, Li J, Xu Q, et al
    Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: A systematic review and meta-analysis.
    J Autoimmun. 2017 Oct 5. pii: S0896-8411(17)30568.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  8. SAREM Z, Bumke-Vogt C, Mahmoud AM, Assefa B, et al
    Glucagon Decreases IGF-1 Bioactivity in Humans, Independently of Insulin, by Modulating Its Binding Proteins.
    J Clin Endocrinol Metab. 2017;102:3480-3490.
    PubMed     Text format     Abstract available


    J Immunol

  9. HOSOKAWA T, Kimura T, Nada S, Okuno T, et al
    Lamtor1 Is Critically Required for CD4+ T Cell Proliferation and Regulatory T Cell Suppressive Function.
    J Immunol. 2017;199:2008-2019.
    PubMed     Text format     Abstract available

  10. UKAH TK, Cattin-Roy AN, Chen W, Miller MM, et al
    On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.
    J Immunol. 2017 Jun 23. pii: ji1700410. doi: 10.4049/jimmunol.1700410.
    PubMed     Text format     Abstract available

  11. WEBB LM, Amici SA, Jablonski KA, Savardekar H, et al
    Correction: PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2017;199:3004.
    PubMed     Text format    


    J Neuroimmunol

  12. MERKER M, Eichler S, Herrmann AM, Wiendl H, et al
    Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis.
    J Neuroimmunol. 2017 Sep 21. pii: S1521-6616(17)30639.
    PubMed     Text format     Abstract available

  13. FERNANDEZ HURST N, Zanetti SR, Baez NS, Bibolini MJ, et al
    Diazepam treatment reduces inflammatory cells and mediators in the central nervous system of rats with experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2017 Sep 30. pii: S0165-5728(17)30297.
    PubMed     Text format     Abstract available

  14. SVEINSSON O, Granqvist M, Forslin Y, Blennow K, et al
    Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis.
    J Neuroimmunol. 2017;312:15-18.
    PubMed     Text format     Abstract available

  15. HESSELMARK E, Bejerot S
    Biomarkers for diagnosis of Pediatric Acute Neuropsychiatric Syndrome (PANS) - Sensitivity and specificity of the Cunningham Panel.
    J Neuroimmunol. 2017;312:31-37.
    PubMed     Text format     Abstract available

  16. WANG Y, Zhang W, Yin J, Lu Q, et al
    Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
    J Neuroimmunol. 2017;312:59-65.
    PubMed     Text format     Abstract available


    Mult Scler

  17. VAN KEMPEN ZL, Rispens T, Killestein J
    Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing".
    Mult Scler. 2017 Oct 1:1352458517734073. doi: 10.1177/1352458517734073.
    PubMed     Text format    


    N Engl J Med

  18. ROSENBAUM JT
    Celiac Disease and Autoimmunity - The Missing Ingredient.
    N Engl J Med. 2017;377:1489-1490.
    PubMed     Text format    


  19. Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed     Text format    

  20. STONE JH, Klearman M, Collinson N
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1494-1495.
    PubMed     Text format    

  21. GONZALES-GAY MA, Loricera J, Blanco R
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493.
    PubMed     Text format    

  22. AKIYAMA M
    Trial of Tocilizumab in Giant-Cell Arteritis.
    N Engl J Med. 2017;377:1493-4.
    PubMed     Text format    


    Neurology

  23. KARGIOTIS O, Safouris A, Petrou VN, Magoufis G, et al
    Teaching NeuroImages: Giant cell arteritis presenting with acute ischemic strokes due to diffuse intracranial stenoses.
    Neurology. 2017;89:e190-e191.
    PubMed     Text format    

  24. TSIVGOULIS G, Papadimitropoulos GN, Katsanos AH, Zompola C, et al
    Teaching NeuroImages: Interferon-induced psoriasis flare in a multiple sclerosis case remits with dimethyl fumarate.
    Neurology. 2017;89:e188-e189.
    PubMed     Text format    


    PLoS One

  25. EBBO M, Grados A, Samson M, Groh M, et al
    Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
    PLoS One. 2017;12:e0183844.
    PubMed     Text format     Abstract available

  26. REN S, Wang Y, Xian L, Toyama T, et al
    Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    PLoS One. 2017;12:e0184398.
    PubMed     Text format     Abstract available

  27. WURTH S, Kuenz B, Bsteh G, Ehling R, et al
    Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    PLoS One. 2017;12:e0182462.
    PubMed     Text format     Abstract available

  28. LIN TS, Hsu PY, Chang CH, Ko CL, et al
    Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.
    PLoS One. 2017;12:e0182344.
    PubMed     Text format     Abstract available

  29. MESSINA S, Solaro C, Righini I, Bergamaschi R, et al
    Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
    PLoS One. 2017;12:e0180651.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: